SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001566044-21-000034
Filing Date
2021-08-12
Accepted
2021-08-12 08:47:15
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20210630.htm   iXBRL 10-Q 1255244
2 EX-10.1 ex101zeronda-executiveempl.htm EX-10.1 118061
3 EX-31.1 vyne-20210630xexx311.htm EX-31.1 9709
4 EX-31.2 vyne-20210630xexx312.htm EX-31.2 9703
5 EX-32.1 vyne-20210630xexx321.htm EX-32.1 5282
6 EX-32.2 vyne-20210630xexx322.htm EX-32.2 5273
12 image_0a.jpg GRAPHIC 33776
  Complete submission text file 0001566044-21-000034.txt   6523536

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20210630.xsd EX-101.SCH 44300
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20210630_cal.xml EX-101.CAL 67575
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20210630_def.xml EX-101.DEF 272754
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20210630_lab.xml EX-101.LAB 593256
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20210630_pre.xml EX-101.PRE 407104
13 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20210630_htm.xml XML 898253
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 211165619
SIC: 2834 Pharmaceutical Preparations